Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.
about
Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018.Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis.
P2860
Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Anticoagulation Use and Clinic ...... rfarin in Atrial Fibrillation.
@en
Anticoagulation Use and Clinic ...... rfarin in Atrial Fibrillation.
@nl
type
label
Anticoagulation Use and Clinic ...... rfarin in Atrial Fibrillation.
@en
Anticoagulation Use and Clinic ...... rfarin in Atrial Fibrillation.
@nl
prefLabel
Anticoagulation Use and Clinic ...... rfarin in Atrial Fibrillation.
@en
Anticoagulation Use and Clinic ...... rfarin in Atrial Fibrillation.
@nl
P2860
P50
P1433
P1476
Anticoagulation Use and Clinic ...... arfarin in Atrial Fibrillation
@en
P2093
Paul K L Chin
Samir Saba
P2860
P304
P356
10.1161/STROKEAHA.116.015150
P407
P577
2016-12-01T00:00:00Z